Bollard CM - Search Results

1

Applications of virus-specific T cell therapies post-BMT.

Motta CM, Keller MD, Bollard CM. Motta CM, et al. Among authors: bollard cm. Semin Hematol. 2023 Jan;60(1):10-19. doi: 10.1053/j.seminhematol.2022.12.002. Epub 2022 Dec 23. Semin Hematol. 2023. PMID: 37080705 Review.

2

T-cell therapies for Epstein-Barr virus-associated lymphomas.

El-Bietar J, Bollard C. El-Bietar J, et al. Pediatr Hematol Oncol. 2011 Nov;28(8):627-39. doi: 10.3109/08880018.2011.628367. Pediatr Hematol Oncol. 2011. PMID: 22023461 Review.

3

T-cell therapy in the treatment of post-transplant lymphoproliferative disease.

Bollard CM, Rooney CM, Heslop HE. Bollard CM, et al. Nat Rev Clin Oncol. 2012 Sep;9(9):510-9. doi: 10.1038/nrclinonc.2012.111. Epub 2012 Jul 17. Nat Rev Clin Oncol. 2012. PMID: 22801669 Free PMC article. Review.

4

The time is now: moving toward virus-specific T cells after allogeneic hematopoietic stem cell transplantation as the standard of care.

Saglio F, Hanley PJ, Bollard CM. Saglio F, et al. Among authors: bollard cm. Cytotherapy. 2014 Feb;16(2):149-59. doi: 10.1016/j.jcyt.2013.11.010. Cytotherapy. 2014. PMID: 24438896 Free PMC article. Review.

5

Will post-transplantation cell therapies for pediatric patients become standard of care?

Lankester AC, Locatelli F, Bader P, Rettinger E, Egeler M, Katewa S, Pulsipher MA, Nierkens S, Schultz K, Handgretinger R, Grupp SA, Boelens JJ, Bollard CM; Westhafen Intercontinental Group. Lankester AC, et al. Among authors: bollard cm. Biol Blood Marrow Transplant. 2015 Mar;21(3):402-11. doi: 10.1016/j.bbmt.2014.07.018. Epub 2014 Jul 23. Biol Blood Marrow Transplant. 2015. PMID: 25064748 Free article. Review.

6

Graft versus leukemia response without graft-versus-host disease elicited by adoptively transferred multivirus-specific T-cells.

Melenhorst JJ, Castillo P, Hanley PJ, Keller MD, Krance RA, Margolin J, Leen AM, Heslop HE, Barrett AJ, Rooney CM, Bollard CM. Melenhorst JJ, et al. Among authors: bollard cm. Mol Ther. 2015 Jan;23(1):179-83. doi: 10.1038/mt.2014.192. Epub 2014 Sep 30. Mol Ther. 2015. PMID: 25266309 Free PMC article.

7

Adoptive immunotherapy with the use of regulatory T cells and virus-specific T cells derived from cord blood.

Hanley PJ, Bollard CM, Brunstein CG. Hanley PJ, et al. Among authors: bollard cm. Cytotherapy. 2015 Jun;17(6):749-755. doi: 10.1016/j.jcyt.2014.12.007. Epub 2015 Jan 24. Cytotherapy. 2015. PMID: 25632003 Free PMC article. Review.

8

Cytotoxic T lymphocytes for leukemia and lymphoma.

Bollard CM, Barrett AJ. Bollard CM, et al. Hematology Am Soc Hematol Educ Program. 2014 Dec 5;2014(1):565-9. doi: 10.1182/asheducation-2014.1.565. Epub 2014 Nov 18. Hematology Am Soc Hematol Educ Program. 2014. PMID: 25696912 Review.

9

General and Virus-Specific Immune Cell Reconstitution after Double Cord Blood Transplantation.

Saliba RM, Rezvani K, Leen A, Jorgensen J, Shah N, Hosing C, Parmar S, Oran B, Olson A, Rondon G, Chen J, Martinez C, Hamdi A, Mehta RS, Chemaly RF, Saunders IM, Bollard CM, Shpall EJ. Saliba RM, et al. Among authors: bollard cm. Biol Blood Marrow Transplant. 2015 Jul;21(7):1284-90. doi: 10.1016/j.bbmt.2015.02.017. Epub 2015 Feb 20. Biol Blood Marrow Transplant. 2015. PMID: 25708219 Free PMC article.

10

T-cell and natural killer cell therapies for hematologic malignancies after hematopoietic stem cell transplantation: enhancing the graft-versus-leukemia effect.

Cruz CR, Bollard CM. Cruz CR, et al. Among authors: bollard cm. Haematologica. 2015 Jun;100(6):709-19. doi: 10.3324/haematol.2014.113860. Haematologica. 2015. PMID: 26034113 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

301 results

Search Page